“HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIRECT IN VIVO DOSIMETRY IS AN IMPORTANT FACTOR IN INCREASING THE EFFECTIVENESS OF TREATMENT AND REDUCING THE INCIDENCE OF COMPLICATIONS”. Voprosy onkologii 65, no. 4 (April 1, 2019): 596–602. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1004.